PEN

Penumbra, Inc.NYSEHealthcare

$330.36+0.43%OpenMarket Cap: $12.96B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-26	Evercore ISI Group	—	Outperform	—
2026-01-20	RBC Capital	—	Sector Perform	—
2026-01-20	Canaccord Genuity	—	Hold	—
2026-01-16	Citigroup	—	Neutral	—
2026-01-16	Jefferies	—	Hold	—
2026-01-16	Truist Securities	—	Hold	—
2026-01-16	Leerink Partners	—	Market Perform	—
2026-01-16	BTIG	—	Neutral	—
2026-01-16	Needham	—	Hold	—
2026-01-16	Baird	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$5.01	$1.59B	9
Fri Dec 31	$6.33	$1.81B	10
Sun Dec 31	$7.60	$2.04B	4
Mon Dec 31	$9.25	$2.26B	2